 Correlations Between Gut Microbiome Changes, Gut Barrier Function, and Immune Homeostasis in COVID-19 Patients: The Role of Gut Microbiota in Immunity and Cancer PreventionPatel, Garg, Nashte, Makhija and Rohini Health Leadership and Quality of Life, 2025, vol. 4, 354 Abstract: Systemic inflammation and immunological dysregulation are linked to COVID-19 infection, and there is mounting evidence that gut barrier failure and gut microbiota dysbiosis are related. Gaining knowledge of these relationships could help explain how diseases develop. By measuring biomarkers and cytokine levels, this research aims to analyze the relationships among gut microbiota alterations, gut barrier function, and immunological homeostasis in COVID-19 patients. Using IBM SPSS (version 26) with Pearson Correlation, Chi-Square testing, independent t-tests, and Multivariate Regression analysis, a comparative study was conducted using gut barrier biomarkers (Zonulin, LPS, I-FABP) and cytokine levels (IL-6, IL-10, TNF-α). In COVID-19 individuals, there were notable variations in gut barrier biomarkers and cytokine levels, with robust associations suggesting a connection between immune dysregulation and gut barrier failure. Gut microbiota dysbiosis and gut barrier dysfunction are significantly associated with immune homeostasis disturbance in COVID-19 patients, which may be a contributing factor to the disease's severity and progression. Date: 2025 There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:4:y:2025:i::p:354:id:354 DOI: 10.56294/hl2025354 Access Statistics for this article More articles in Health Leadership and Quality of Life from AG Editor |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.